Construction of universal quantitative models for determination of roxithromycin and Erythromycin ethylsuccinate (cas 1264-62-6) in tablets from different manufacturers using near infrared reflectance spectroscopy

Add time:08/13/2019    Source:sciencedirect.com

Universal quantitative models using NIR reflectance spectroscopy were developed for the analysis of API contents (active pharmaceutical ingredient) in roxithromycin and Erythromycin ethylsuccinate (cas 1264-62-6) tablets from different manufacturers in China. The two quantitative models were built from 78 batches of roxithromycin samples from 18 different manufacturers with the API content range from 19.5% to 73.9%, and 66 batches erythromycin ethylsuccinate tablets from 36 manufacturers with the API content range from 28.1% to 70.9%. Three different spectrometers were used for model construction in order to have robust and universal models. The root mean square errors of cross validation (RMSECV) and the root mean square errors of prediction (RMSEP) of the model for roxithromycin tablets were 1.84% and 1.45%, respectively. The values of RMSECV and RMSEP of the model for erythromycin ethylsuccinate tablets were 2.31% and 2.16%, respectively. Based on the ICH guidelines and characteristics of NIR spectroscopy, the quantitative models were then evaluated in terms of specificity, linearity, accuracy, precision, robustness and model transferability. Our study has shown that it is feasible to build a universal quantitative model for quick analysis of pharmaceutical products from different manufacturers. Therefore, the NIR method could be used as an effective method for quick, non-destructive inspection of medicines in the distribution channels or open market.

We also recommend Trading Suppliers and Manufacturers of Erythromycin ethylsuccinate (cas 1264-62-6). Pls Click Website Link as below: cas 1264-62-6 suppliers

Prev:Simultaneous determination of Erythromycin ethylsuccinate (cas 1264-62-6) and its metabolite erythromycin in human plasma using liquid chromatography–electrospray ionization mass spectrometry for clinical study
Next:Determination of Erythromycin ethylsuccinate (cas 1264-62-6) by liquid chromatography)